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Abstract  25 
Mitochondria play essential metabolic functions in eukaryotes. Although their major role is the 26 
generation of energy in the form of ATP, they are also involved in maintenance of cellular redox 27 
state, conversion and biosynthesis of metabolites and signal transduction. Most mitochondrial 28 
functions are conserved in eukaryotic systems and mitochondrial dysfunctions trigger several 29 
human diseases.  30 
By using multi-omics approach, we investigate the effect of methionine supplementation on yeast 31 
cellular metabolism, considering its role in the regulation of key cellular processes. Methionine 32 
supplementation induces an up-regulation of proteins related to mitochondrial functions such as 33 
TCA cycle, electron transport chain and respiration, combined with an enhancement of 34 
mitochondrial pyruvate uptake and TCA cycle activity.  This metabolic signature is more noticeable 35 
in cells lacking Snf1/AMPK, the conserved signalling regulator of energy homeostasis. Remarkably, 36 
snf1 cells strongly depend on mitochondrial respiration and suppression of pyruvate transport is 37 
detrimental for these cells in methionine condition, indicating that respiration mostly relies on 38 
pyruvate flux into mitochondrial pathways.  39 
These data provide new insights into the regulation of mitochondrial metabolism and extends our 40 
understanding on the role of methionine in regulating energy signalling pathways. 41 
 42 
 43 
44 
3 
 
Introduction 45 
To tackle the central cell biology issue of how a specific genotype is able to generate a given 46 
phenotype in certain environmental conditions, a useful approach is to start by unravelling the 47 
complexity of the phenotypic features generated by the interacting genetic and nutritional 48 
perturbations. Here, we approach this issue by considering Snf1/AMPK, the key signalling 49 
regulator of energy homeostasis in eukaryotes [1] and the amino acid methionine, an essential 50 
player of the one-carbon metabolism [2]. In Saccharomyces cerevisiae Snf1 protein complex is a 51 
central component of glucose signalling pathway. It promotes respiratory metabolism and 52 
gluconeogenesis, being necessary for growth in low glucose or alternative carbon sources [3]. It is 53 
made by the catalytic α subunit (Snf1), the γ subunit (Snf4) and one of the three alternative β 54 
subunits (Sip1, Sip2, Gal83), which determine the intracellular localization of the kinase [3,4]. 55 
Snf1/AMPK is active when the catalytic α subunit is phosphorylated on Thr210 by one of the three 56 
constitutive active kinases Sak1, Tos3 or Elm1 [5]. Snf1 activation requires also the association 57 
between α and γ subunits, which stabilizes the active conformation of the kinase [5]. In response 58 
to high glucose concentrations, Snf1 is inactivated through de-phosphorylation of Thr210 by the 59 
phosphatase Glc7/Reg1 [6,7]. Phosphorylation of Ser214, inside the activation loop, has been 60 
reported as an additional mechanism for downregulating Snf1/AMPK kinase activity [8].  61 
Upon activation, Snf1 phosphorylates a number of transcription factors, activating some and 62 
repressing others [3]. Specifically, active Snf1 causes the translocation to the cytoplasm of Mig1, 63 
thus leading to the expression of glucose repressed-genes [9,10]. Besides Mig1, Snf1 activates 64 
Cat8 and Sip4, which regulate the expression of gluconeogenic genes [11,12], and Adr1, which 65 
activates the expression of the alcohol dehydrogenase gene ADH2 and genes of glycerol 66 
metabolism, fatty acid utilization and peroxisome biogenesis [13,14]. Snf1 also phosphorylates and 67 
regulates the nuclear localization of Hcm1, a forkhead transcription factor, leading to increased 68 
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transcription of genes involved in respiration during nutrient scarcity [15]. Furthermore, Snf1 69 
stimulates the activity of several metabolic enzymes, such as the glycerol-3-phosphate 70 
dehydrogenase isoform Gpd2 [16] and the acetyl-CoA carboxylase Acc1 [17,18]. Although 71 
Snf1/AMPK function has been mostly studied in respiration-dependent growth [19–21], some 72 
reports indicate that it is active even in glucose repression [22–24]. In keeping with these data, we 73 
recently reported that Snf1/AMPK phosphorylation on Thr210 is slightly detectable also in high 74 
glucose [25] and, in this condition, it regulates G1/S cell-cycle transition, proper spindle 75 
orientation and cellular metabolism [25–28]. Moreover, Snf1/AMPK interacts with and 76 
phosphorylates the adenylate cyclase Cyr1 in a nutrient-independent manner and negatively 77 
regulates intracellular cAMP content as well as PKA-dependent transcription [29]. 78 
The sulfur amino acid methionine (Met) is the precursor of S-adenosylmethionine (SAM), the 79 
universal cellular methyl donor [30–33]. Methionine metabolism regulates key biological functions 80 
in mammalian cells, such as cell proliferation, metabolism, stem cell maintenance and embryonic 81 
development [34,35]. It is well-known that methionine-restriction extends lifespan across different 82 
species [36] and in human fibroblast this is due to a decrease of mitochondrial oxidative 83 
phosphorylation [37]. Importantly, SAM is involved in G1 cell-cycle regulation in yeast [38] and 84 
stimulation of SAM synthesis triggers Snf1 activation in yeast [39].  85 
Here, we have uncovered new links between methionine metabolism and the Snf1/AMPK 86 
pathway. By using metabolomics profiling, metabolic flux analysis and mitochondrial proteomics, 87 
we have discovered a novel function for Snf1/AMPK as a negative regulator of aerobic respiration 88 
and mitochondrial pyruvate uptake, in methionine and glucose-repressing conditions.  89 
90 
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 91 
Results 92 
Methionine addition affects proliferation and metabolism in the absence of Snf1 93 
Stimulation of S-adenosylmethionine (SAM) synthesis leads to Snf1 activation [39]. Accordingly, 94 
Snf1-dependent phosphorylation of an acetyl-coenzyme A carboxylase 1 derived reporter [40] 95 
increased upon methionine supplementation (Fig. 1A). 96 
Then, to better understand the relation between methionine metabolism and Snf1 activity, the 97 
prototrophic CEN.PK JT4 snf1Δ strain and its control wild type were grown on synthetic medium 98 
containing 2% glucose and increasing concentrations of methionine (from 0.05 g/l up to 1.5 g/l). 99 
Methionine and SAM supplementation (Fig. 1B, Supplementary Fig. S1A) affected both 100 
proliferation and budding index of cells lacking Snf1 (Fig. S1B).  101 
Addition of methionine (0.1 g/l, 0.67 mM), which was uptaken at similar rates by wt and snf1Δ 102 
strains, significantly impaired glycerol secretion in cells lacking Snf1, while no alterations were 103 
observed on glucose uptake, ethanol, acetate and glycerol secretion rates, which were already 104 
lower in the snf1Δ mutant (Fig. 1C).  105 
To gain more insight into the relevant intracellular metabolic changes upon SNF1 deletion and 106 
methionine addition, we next performed a metabolomic profiling analysis (Fig. 2A, Supplementary 107 
Fig. S2A-B, Supplementary Table S1). In the control strain grown in the presence of methionine, 108 
most metabolites decreased, mainly amino acids, intermediates of the citric acid cycle and the 109 
urea cycle (Fig. 2A, Supplementary Fig. S2B). On the contrary, SNF1 deletion, in combination with 110 
methionine addition, promoted an increase in the level of amino acids, tricarboxylic acids, as well 111 
as TCA cycle derivatives and urea cycle intermediates, with only few exceptions (Fig. 2A, 112 
Supplementary Fig. S2B). One of the most upregulated metabolites was trehalose, which was 113 
more abundant in snf1Δ cells compared to wt, and was strongly up-regulated in the presence of 114 
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methionine (Fig. 2A, Supplementary Fig. S2B), possibly due to the increased activity of trehalose-6-115 
phosphate synthase upon methylation [41]. 116 
Interestingly, intracellular homocysteine increased in cells lacking Snf1 (Fig. 2A, Supplementary 117 
Fig. S2B) and all metabolites of the methionine cycle were more up-regulated in the snf1Δ mutant 118 
supplemented with methionine in comparison with the control (Fig. 2A-C). Moreover, in this 119 
condition, S-adenosylmethionine and S-adenosylhomocysteine ratio (SAM/SAH) decreased in the 120 
wild type, while increased in the snf1Δ mutant, further confirming the unbalance of methionine 121 
metabolism due to Snf1 loss (Fig. 2D). 122 
Taken together, these data indicate that methionine supplementation induces a general 123 
remodelling of metabolism, being more evident in cells lacking Snf1. 124 
Mitochondrial proteome shows an increase of proteins involved in aerobic respiration in 125 
methionine medium  126 
To gain a better insight in the up-regulation of TCA cycle intermediates following SNF1 deletion 127 
and methionine treatment, a label-free shotgun proteomics approach was used to investigate the 128 
mitochondrial proteome of wild type and snf1Δ cells grown without and with methionine. The 129 
corresponding Venn diagram and workflow are shown in Fig. 3A and Supplementary Fig. S3, 130 
respectively. Among the 1236 proteins common to all data sets, Supplementary Table S2 reports 131 
only the proteins whose differences were statistically significant according to ANOVA test. More 132 
than 89% of them were reported as mitochondrial according to Yeast Mine software and [42], 133 
indicating a significant enrichment in mitochondrial components. Remarkably, Snf1 was found 134 
associated to mitochondria, further confirming its mitochondrial localization [43]. Due to the high 135 
sensitivity of the analysis, non-mitochondrial proteins were also identified, as previously reported 136 
[42], mainly localized in compartments tightly associated to mitochondria (such as endoplasmic 137 
reticulum, Golgi and vacuole). A principal component analysis (PCA), carried out on the four data 138 
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sets (wt, wt + M, snf1Δ, snf1Δ + M) confirmed that, as expected, each condition exerted a specific 139 
detectable effect on protein expression. However, the proteome of both wt and snf1∆ moved 140 
towards negative values of the Component 1 upon methionine addition (Fig. 3B). 141 
We then carried out pairwise analyses focusing on the following comparisons: snf1Δ/wt (Fig. 3C, 142 
Supplementary Table S3), wt + M/wt (Fig. 3D, Supplementary Table S4), snf1Δ + M/snf1Δ (Fig. 3E, 143 
Supplementary Table S5) and snf1Δ + M/wt + M (Fig. 3F, Supplementary Table S6). SNF1 deletion 144 
mostly induced an up-regulation of many proteins related to cellular transport (transmembrane 145 
transport, mitochondrial transport, late endosome to vacuole transport, Golgi to endosome 146 
transport, heme transport) and amino acids biosynthesis (cellular amino acid biosynthetic process, 147 
glutamate biosynthetic process, serine family amino acid biosynthetic process) (Fig. 3C, 148 
Supplementary Table S3), in keeping with metabolomics analysis (Fig. 2) and with previously 149 
reported transcriptional up-regulation of genes related to transport, amino acids biosynthesis and 150 
iron homeostasis of the snf1Δ mutant [26].  151 
Methionine induced a down-regulation of proteins involved in sterol and ergosterol biosynthesis 152 
only in snf1Δ mutant (Fig. 3E, Supplementary Table S5). In addition, proteins involved in ribosome 153 
biogenesis and RNA processing were down-regulated in both wt and snf1Δ cells (Fig. 3D, E and 154 
Supplementary Tables S4-S5). The identification of this class of proteins is not surprising, in 155 
keeping with previous data showing the association of ribosomes with mitochondria [42,44]. 156 
Remarkably, in both strains methionine induced an up-regulation of proteins related to 157 
mitochondrial functions, such as TCA cycle (i.e. Mdh1, Sdh1,2,4, Cit1, Idh2, Idp1), electron 158 
transport chain and aerobic respiration (i.e. Cyt1, Qcr2,7,10, Cir2, Cyb2, Cor1, Cyc1, Rip1, Mam33), 159 
as well as proteins related to redox processes (Fig. 3D-E and Supplementary Tables S4-S5), being 160 
more up-regulated in snf1Δ mutant (Fig. 3F, Supplementary Table S6).  161 
Therefore, proteins related to mitochondrial respiration increase in methionine-medium. 162 
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Methionine addition stimulates mitochondrial respiration in the absence of Snf1 163 
To test whether methionine supplementation and SNF1 deletion were involved in the regulation 164 
of mitochondrial activity, we measured several parameters associated to active mitochondria. Loss 165 
of SNF1 determined a striking increase of mtDNA copy number, mitochondrial membrane 166 
potential, as well as oxygen consumption of mitochondria isolated from cells grown in 167 
methionine-supplemented media (Fig. 4A-C). In details, although mitochondria isolated from 168 
snf1Δ mutant oxidized succinate and NADH to rates comparable to those of the control, they 169 
displayed a higher oxidation rate when NADH was used as a substrate in cells grown in methionine 170 
medium (Fig. 4C). In keeping with the higher respiration rate, antimycin A, an inhibitor of the 171 
mitochondrial electron transport chain complex III [45,46], had a dramatic impact on the growth 172 
rate of the snf1Δ mutant in the presence of methionine (Fig. 4D). 173 
Despite the more sustained mitochondrial metabolism, intracellular basal ATP levels decreased 174 
upon SNF1 deletion in combination with methionine (Fig. 4E), indicating that energy consuming 175 
processes, i.e. fatty acids and lipid droplets accumulation (Fig. 2A and Supplementary Fig. S4A, 176 
respectively), trehalose (Fig. 2A) and SAM biosynthesis (Fig. 2D) were draining energy in this 177 
growth condition. 178 
Altogether, these data confirm that methionine has a relevant effect on the metabolism of cells 179 
lacking Snf1, highlighting its essential involvement in mitochondrial respiration. 180 
Methionine addition stimulates pyruvate transport into mitochondria in the absence of Snf1 181 
To gain further insight into mitochondrial substrate utilization, we cultured cells in the presence of 182 
[U-13C6] glucose and determined steady-state isotopic labelling from which important intracellular 183 
flux partitioning ratios were calculated [47]. Then, a metabolic flux analysis was performed 184 
integrating these intracellular flux ratios (Supplementary Fig. S5A), consumption and secretion 185 
rates (Fig. 1C) in a yeast model of central carbon metabolism [47,48] (Fig. 5A, Supplementary Fig. 186 
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S5B). snf1Δ mutant displayed a larger flux of carbon towards mitochondria as compared to the 187 
control, showing more pyruvate transported into these organelles in both conditions (Fig. 5B, 188 
Supplementary Fig. S5B). Strikingly, in methionine supplementation, pyruvate transport towards 189 
mitochondria, TCA cycle activity and respiration were more up-regulated in the snf1Δ mutant than 190 
wt (Fig. 5A-C, Supplementary Fig. S5B).  191 
The fraction of oxaloacetate (OAA) generated from mitochondrial malate by malate 192 
dehydrogenase (i.e. oxidative TCA cycle activity) [49] was then calculated. As expected, in the wild 193 
type, under glucose repression, TCA cycle oxidative activity was low [49] and increased from 4.6% 194 
to 21.5% in methionine growth condition (Fig. 5C). In contrast, a lower glucose-repressed 195 
metabolism was detectable in the snf1Δ mutant, being oxidative TCA cycle activity 29.25% without 196 
methionine and raising up to 47% in the presence of methionine (Fig. 5C).  197 
The downregulation of glycerol secretion suggested a sustained mitochondrial oxidation of 198 
cytosolic NADH in the presence of methionine in cells lacking Snf1 (Fig. 1C). Remarkably, the 199 
model predicted an increase of the oxygen consumption in the snf1Δ cells (Fig. 5A, Supplementary 200 
Fig. S5B), in accordance with the stimulation of mitochondrial respiration in cells lacking Snf1 201 
above reported (Fig. 4C). 202 
Overall, our results support an inhibitory function of Snf1/AMPK on respiration as well as on TCA 203 
cycle in glucose repressed conditions, further enforced in methionine-medium.  204 
Mpc1 function has a key role for methionine-dependent respiratory activity in the absence of Snf1  205 
Overall our data indicate that methionine stimulates mitochondrial pyruvate transport and 206 
respiration. Therefore, we examined the level of the three subunits of the MPC (Mitochondrial 207 
Pyruvate Carrier) complex in strains expressing HA-tagged versions of Mpc1,2,3. While Mpc1 208 
levels were almost unchanged, the level of Mpc2 and Mpc3 strongly increased in methionine 209 
supplementation, both in wt and snf1Δ cells (Fig. 6A), suggesting that the increased mitochondrial 210 
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functionality may depend on the upregulation of MPC subunits. However, although the effect of 211 
methionine was similar in both strains, mitochondrial respiration was physiologically more 212 
noticeable in cells lacking Snf1 (Fig. 4). Thus, we treated cells with UK5099, which covalently binds 213 
to MPC and blocks pyruvate transport [50]. While only a slight decrease of proliferation was 214 
observed in both strains, a dramatic slow-down of growth rate occurred in cells lacking Snf1 in the 215 
presence of methionine (Fig. 6B).  216 
Loss of the major structural subunit of the mitochondrial pyruvate carrier, Mpc1, results in 217 
defective mitochondrial pyruvate uptake [51,52]. Thus, we tested the effect of MPC1 deletion on 218 
the snf1Δ mutant grown with and without methionine in the medium. mpc1Δ cells grew slower 219 
than the control, as previously reported [51], also in the presence of methionine (Fig. 6C). 220 
Remarkably the snf1Δmpc1Δ double mutant had a major growth defect only in methionine 221 
medium (Fig. 6C), in accordance with data obtained with the inhibitor UK5099 (Fig. 6B). The strong 222 
reliance on pyruvate transport and respiration of snf1Δ cells was further confirmed by the 223 
complete growth arrest of the snf1Δmpc1Δ mutant treated with Antimycin A (Fig. 6D), which 224 
however had no effect on cellular viability (data not shown). 225 
Taken together, our results indicate that respiration due to Snf1 loss mostly relies on the flux of  226 
pyruvate into mitochondria. 227 
228 
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Discussion  229 
Methionine cycle, being a key metabolic network which integrates biosynthesis, one-carbon 230 
metabolism and epigenetics, regulates important biological functions such as cell proliferation, 231 
metabolism, stem cell maintenance and embryonic development [34,35]. For these reasons and 232 
also because its regulation is mostly unknown, methionine metabolism still needs to be 233 
investigated deeper. In the present study, we showed that methionine metabolism has a strong 234 
impact on cellular and metabolic features of proliferating yeast cells, collecting evidences that 235 
most of them are tightly connected with Snf1/AMPK.  236 
Snf1/AMPK, an important cellular energy sensor, is conserved from yeast to humans [1]. In yeast, 237 
it is required for the expression of glucose-repressed genes and cells lacking Snf1 are unable to 238 
grow on non-fermentable carbon sources, such as glycerol or ethanol. Paradoxically, while in the 239 
absence of glucose Snf1 is required to increase respiration, in high glucose condition, oxidative 240 
phosphorylation sustains growth and energy production in snf1 cells [26], indicating an 241 
unconventional role of Snf1 under glucose repression. Here we showed that although methionine 242 
supplemented to the medium was rather low (0.1 g/L) and ineffective to inhibit wild type growth 243 
([53], Fig. 1B), in cells lacking Snf1, it induced a general slow-down of proliferation, combined with 244 
enhanced mitochondrial DNA, NADH oxidation, TCA cycle flux, and mitochondrial pyruvate uptake 245 
(summarized in Fig. 7).  246 
Notably, an imbalance of methionine cycle was evident in cells lacking Snf1 even in methionine-247 
free medium. In fact, intracellular homocysteine, a thiol amino acid, whose dysfunction is 248 
associated with a multitude of human diseases [54], increased in snf1 cells and all metabolites of 249 
this cycle as well as methylation potential (SAM/SAH) were further up-regulated in the presence of 250 
methionine (Fig. 2). In support of this, methionine metabolism has been recently reported to be 251 
tightly connected with Snf1/AMPK since SAM accumulation enhances Snf1 activation [39], 252 
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highlighting also a Snf1-dependent function in fine tuning methionine metabolism in a feedback 253 
loop (Fig. 7). 254 
More interestingly, although in methionine medium many proteins involved in electron transport 255 
chain and aerobic respiration were up-regulated both in wild type and in snf1 cells (Fig. 3D-E), 256 
inhibition of mitochondrial respiration was detrimental only for cells lacking Snf1 (Fig. 4D), 257 
indicating a reliance on mitochondrial function, further supported by the up-regulation of redox 258 
processes only in that condition (Fig. 3F). 259 
Thus, our results clearly indicate that the addition of a small amount of methionine in the medium 260 
has a strong impact only if Snf1/AMPK is inactive and provides novel insights into methionine-261 
dependent regulation of proliferation and mitochondrial metabolism. 262 
Several lines of evidences support the connection between methionine metabolism and 263 
mitochondrial function: i) metabolism of yeast strains with high intracellular SAM content [55] 264 
depends on elevated TCA cycle fluxes and respiration activity [56]; ii) homocysteine metabolism 265 
regulates mitochondrial respiration in T cells and mitochondrial membrane potential in yeast 266 
[57,58]; iii) in human fibroblast, the activity of oxidative phosphorylation by complex IV decreases 267 
in methionine restriction, due to the reduced COX1 level [37]. 268 
In support of these data, we confirm the connection between methionine metabolism and 269 
mitochondrial respiration showing, in addition, the key role of Snf1/AMPK in such a regulation.  270 
It is well known that in glucose containing medium, yeast cells metabolize glucose predominantly 271 
through glycolysis, followed by alcoholic fermentation. Since glucose represses functions 272 
connected to TCA cycle and respiration, only a relatively small fraction of glycolytically produced 273 
pyruvate is translocated into mitochondria and converted to acetyl-CoA. Our metabolic flux 274 
analysis indicates that methionine supplementation stimulates pyruvate transport into 275 
mitochondria in glucose-repressing conditions (Fig. 5). Remarkably, snf1Δmpc1Δ mutant shows a 276 
13 
 
slow growth phenotype in methionine medium (Fig. 6C), highlighting the physiological relevance 277 
of Mpc1 function in cells lacking Snf1.  278 
The activity of the Mpc1 carrier is crucial to determine the fate of pyruvate, it is involved in the 279 
triggering of the Warburg effect and is considered a potential target for cancer therapy [59]. 280 
Moreover, the role of protein kinase AMPK in the regulation of MPC1 expression has recently 281 
emerged [60]. Decreased MPC1 expression promotes the maintenance of stemness of cancer cells, 282 
which become more migratory and resistant to both chemotherapy and radiotherapy [61,62]. 283 
Conversely, the inhibition of pyruvate mitochondrial transport by MPC inhibitor UK5099 activates 284 
AMPK [63]. Collectively, the above studies, together with our data, support a new link between 285 
AMPK pathway and mitochondrial pyruvate transport. Strikingly, the coexistence of glycolysis and 286 
functional TCA cycle activity and OXPHOS offers a selective metabolic advantage for cancer cell 287 
proliferation and tumorigenesis [64,65]. Moreover, some studies highlight the double-edged 288 
function of AMPK in the regulation of tumorigenic potential, showing either an anti-tumorigenic or 289 
a pro-tumorigenic function [66,67]. Therefore, in future studies it will be interesting to dissect the 290 
molecular mechanism of pyruvate metabolism by Snf1/AMPK along with its conservation in 291 
eukaryotic systems.  292 
Besides respiratory function, in snf1Δ cells grown in the presence of methionine, there was also a 293 
significant decrease of several proteins involved in ergosterol biosynthesis, among which Erg1, 294 
Erg4, Erg6 and Scs7. Remarkably, mutants with deficiency in ergosterol biosynthesis accumulate S-295 
adenosylmethionine [55], in accordance with our data showing a significant increase of this 296 
metabolite in snf1Δ cells (Fig. 2C). Moreover, the down-regulation of SAH1 expression impairs 297 
sterol synthesis, leading to a 4-fold elevated squalene levels [54]. Egr1, involved in squalene 298 
biosynthesis, is downregulated in cells lacking Snf1, which also show S-adenosylhomocysteine 299 
accumulation (Fig. 2C).  300 
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Interestingly, the proteomics analysis also highlights the down-regulation of glycosylation and 301 
vacuolar transport processes in snf1Δ cells grown in methionine condition (Fig. 5F, Supplementary 302 
Table S6). Kar2, the ATPase involved in protein import/export into the ER [68], was down-303 
regulated too, in accordance with studies reporting the involvement of Snf1 in ER stress response 304 
[69–71].  305 
Finally, histone deacetylation proteins were down-regulated in the absence of Snf1 (Fig. 3C, 306 
Supplementary Table S3). It was previously reported that inactivation of SNF1 globally decreases 307 
intracellular pool of acetyl-CoA as well as histone acetylation [72]. Therefore, we hypothesize that 308 
the downregulation of histone deacetylation functions here presented could be a consequence of 309 
the reduced level of acetylation in the snf1∆ strain [72]. 310 
Taken together, our results shed significant light on the interplay among Snf1/AMPK activity, 311 
methionine and mitochondrial metabolism in glucose-repressing conditions and extend our 312 
mechanistic understanding of how methionine can influence cell fate.  313 
 314 
315 
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 316 
Material and methods 317 
Yeast strains and growth conditions 318 
S. cerevisiae strains used in this study are reported in Table 1. Synthetic medium (SD) contained 319 
2% glucose, 6.7 g/L of Yeast Nitrogen Base without amino acids (Difco). Methionine was added to 320 
the concentrations indicated in figure legends. In these conditions, cells exhibit exponential 321 
growth between OD600nm = 0.1  (approximately equivalent to 2*10
6 cells/ml) and OD600nm = 2.5 322 
(5*107 cells/ml); all experiments were performed in exponential phase of growth (OD600nm0.5-1). 323 
Antimycin A was added to a final concentration of 1 µg/ml from 2 mg/ml stock in 100% ethanol, 324 
UK5099 was added to a final concentration of 50 µM from 10 mM stock in 100% DMSO; the same 325 
volume of solvent was added in the control cultures. To evaluate Snf1 activity, phosphorylation of 326 
the reporter ACC1-HA was assayed in a strain transformed with the plasmid pYX242-ACC1-GFP-HA 327 
(or pYX242-ACC1-S79A-GFP-HA as negative control) [40]. 328 
Protein extraction and immunoblotting 329 
Cells were harvested by filtration and lysed in 250 µl ice-cold lysis buffer (50 mM Tris pH 7.5, 150 330 
mM NaCl, 0.1, Nonidet p-40, 10% glycerol) with 1 mM PMSF, protease inhibitor mix (Complete 331 
EDTA free protease inhibitor mixture tablets; Roche) and phosphatase inhibitor mix (Cocktail II, 332 
Sigma-Aldrich). An equal volume of acid-washed glass beads (Sigma-Aldrich) was added before 333 
disruption. Cells were broken by 20 cycles of vortex and ice of 1 min each. Protein concentration 334 
was determined with Bio-Rad protein assay. After addition of SDS-sample buffer, crude extract 335 
was boiled at 98 °C for 5 min. 336 
Anti-phospho-Acetyl-CoA Carboxylase (Ser79) antibody (Cell Signaling Technology®) and anti-HA 337 
antibody (Roche) were used to perform immunoblotting following the manufacturer’s instruction.  338 
mtDNA quantification 339 
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Relative mtDNA was quantified by real-time PCR. Primers based on the cDNA sequences of 340 
nuclear-encoded ACT1 and mitochondrial-encoded COX1 genes were designed with Primer 341 
Express 3.0 (Applied Biosystems, Life Technologies) and purchased from Invitrogen (Life 342 
Technologies, sequences available upon request). For each strain analyzed the difference of the 343 
threshold cycle number (CT) between COX1 and ACT1 (ΔCt) was used to calculate the mtDNA copy 344 
number per cell, which was equal to 2-ΔCT [73].  345 
Metabolites analysis 346 
Intracellular metabolites were extracted and analysed by GC-MS. Briefly, around 5 mg of cells in 347 
exponential phase of growth (0.7 OD600nm) were harvested by filtration and quenched with 1.5 ml 348 
50% MeOH at T<-40 °C, then samples were centrifuged at 13000 rpm for 1 min and supernatant 349 
was discarded. To extract metabolites, 400 µl of ice-cold chloroform, 800 µl of 50% MeOH and 20 350 
µl of 2 mM norvaline (as internal standard) were added and samples were stirred by vortex for 30 351 
min at 4 °C. After 5 min centrifugation at 4 °C, the obtained supernatant was concentrated 352 
through evaporation. Samples were subsequently derivatized with MSTFA (N-Methyl-N-353 
(trimethylsilyl) trifluoroacetamide) in an automated WorkBench (Agilent Technologies) and 354 
analysed with 7200 accurate-mass Q-TOF GC/MS (Agilent Technologies). Data processing and 355 
analysis were performed with Mass Hunter and Mass Profiler Professional software (Agilent 356 
Technologies). Raw data were normalized on the norvaline (internal standard) signal and on the 357 
collected cell dry weight and reported in Supplementary Table S1. 358 
Glucose uptake and glycerol, acetate, pyruvate and ethanol productions were determined by HPLC 359 
analysis using a Waters Allianc 2695 separation module (Waters, Milford, MA, USA) equipped with 360 
a Rezex ROA-Organic Acid H+ (8%) 300 mm × 7.8 mm column (Phenomenex Inc., USA), coupled to 361 
a Waters 2410 refractive index detector and a Waters 2996 UV detector. Separation was carried 362 
out at 65 °C with 0.005 M H2SO4 as the mobile phase at a flow rate of 0.6 ml/min. The 363 
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physiological parameters: maximum specific growth rate, biomass yield on glucose and specific 364 
glucose consumption rate were calculated during the exponential growth phase, as described [74]. 365 
Methionine uptake was measured by H-NMR on the medium of exponentially growing cells. 366 
Briefly, cells grown in the presence of 0.1 g/L methionine were collected by filtration and 367 
resuspended in fresh medium containing 0.1 g/L methionine at a final concentration of 0.1 368 
OD600nm. Media were then collected every hour until cells reached the concentration of 1 OD600nm.  369 
S-Adenosyl methionine and S-adenosyl homocysteine were measured using the SAM-SAH ELISA kit 370 
assay (Cells Biolabs©) following the manufacturer’s instructions. 371 
13C-labelling experiments  372 
All labelling experiments were performed in batch cultures assuming pseudo-steady-state 373 
conditions during the exponential growth phase in respiro-fermentative conditions [47,75]. 13C-374 
labelling of proteinogenic amino acids was achieved by growth on 20 g/L glucose as a mixture of 375 
80% (w/w) unlabelled and 20% (w/w) uniformly labeled [U-13C]glucose (13C, 99 %; Cambridge 376 
Isotope Laboratories, Inc). Cells from an overnight minimal medium culture were washed and used 377 
for inoculation below an OD600 of 0.03. 
13C-labelled biomass aliquots were harvested by 378 
centrifugation during the mid-exponential growth phase at an OD600 of ≤1. Cells (about 0.3 mg of 379 
dry biomass) were washed once with sterile water and hydrolysed in 150 µL 6 M HCl at 105 °C for 380 
6 h. The hydrolysate was dried in a heating block at 80 °C under a constant airflow. Before the 381 
GC/MS analyses all samples were subjected to a derivatization step as follows. Each sample was 382 
resuspended in 30 µL of acetonitrile, followed by 30 µL of MBDSTFA (N-methyl-N-ter-383 
butyldimethylsilyl-trifluoroacetamide). The resulting mixture, contained in a closed vial, was 384 
stirred for 10 min and centrifuged for 15 sec. Then, the vial was incubated at 85 °C. After 1 h, the 385 
sample slowly reached room temperature and was analysed. All the derivatized samples were 386 
processed by using a ISQ™ QD Single Quadrupole GC-MS (Thermo Fisher) equipped with a VF-5ms 387 
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(30 m x 0.25 mm i.d. x 0.25 µm; Agilent Technology). Injection volume: 1 µL. Oven program: 140 °C 388 
for 1 min; then 10 °C/min to 310 °C for 1 min; Run Time 15 min. Helium was used as the gas 389 
carrier. SS Inlet: Mode Split. Split flow: 15 mL/min. Split ratio: 1/15. Inlet temperature: 270 °C. 390 
Flow 1.0 mL/min. MS transfer line: 280 °C. Ion source: 280 °C. Ionization mode: electron impact: 391 
70 eV. Acquisition mode: full scan. 392 
A METAFOR (metabolic flux ratio) analysis [47] was perfomed on the generated GC-MS data: the 393 
mass isotopomer distribution of proteinogenic amino acids was used to calculate the split ratios of 394 
key branching points of yeast central metabolism using the software FIAT FLUX [48].  395 
13C-constrained metabolic flux analysis  396 
Intracellular flux ratios , consumption and secretion rates were integrated in a model of yeast 397 
central metabolism using the NETTO subprogram of the Fiat Flux software, to obtain network-398 
wide absolute fluxes [47,48].  399 
The stoichiometric model for 13C-constrained metabolic flux analysis comprises the major 400 
pathways of yeast central carbon metabolism [76]. The model used contains 30 fluxes and 28 401 
metabolites. To calculate intracellular fluxes, the stoichiometric model was constrained with five 402 
extracellular fluxes (growth rate, glucose uptake rate and production rates of ethanol, glycerol and 403 
acetate) and five intracellular flux ratios (fraction of cytosolic oxaloacetate originating from 404 
cytosolic pyruvate, fraction of mitochondrial oxaloacetate derived through anaplerosis, fraction of 405 
phosphoenol-pyruvate originating from cytosolic oxaloacetate, upper and lower bounds of 406 
mitochondrial pyruvate derived through malic enzyme). Only NADH-dependent isocitrate 407 
dehydrogenase activity (Idh1 and Idh2) was considered in the model; NADP-specific isocitrate 408 
dehydrogenase activity was neglected. Mass balances of O2, CO2 and ATP production and 409 
consumption were excluded from the analyses. The overly constrained system was solved by a 410 
least square optimization as described in [77]. 411 
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ATP assay 412 
ATP content was quantified using the BacTiter-Glo™ Luminescent Assay (Promega®), following the 413 
manufacturer’s instructions. Briefly, cells in exponential growth phase were collected and diluted 414 
at 0.3 OD600nm and 100 µl of each sample was assayed in triplicate in a 96-well plate. An equal 415 
volume of BacTiter-GLO™ was then added to each well and the measurement was carried out 416 
after a brief incubation at room temperature (7 min). The measurement was performed at a 417 
wavelength of 560 nm with a Cary Eclipse© Luminometer.  418 
Flow cytofluorimetric (FACS) analysis 419 
FACS analysis were performed with the FACSCalibur© Cytofluorimeter and the CellQuest Pro© 420 
software as described [27]. Cells were collected at the indicated time points and independently 421 
stained with 175 nM 3,3’-dihexyloxacarbocyanine Iodide (DiOC6) to measure mitochondrial 422 
potential, with 20 nM Mitotracker green (MTG) to measure the total mitochondrial content. FACS 423 
data were analysed with Flowing Software© 2 or with the WinMDI© software which provided 424 
quantifications and statistical analysis.  425 
Mitochondrial purification 426 
The isolation of mitochondria was carried out as previously reported [78]. In details, cell walls 427 
were enzymatically degraded with Zymolyase. The resulting spheroplasts were disrupted by 13 428 
strokes in a cooled Potter-Elvehjem homogenizer in hypotonic medium. Cytosolic and 429 
mitochondrial fractions were separated by differential centrifugation. Mitochondria were spun 430 
down gently for 10 min at 10,000 x g and were resuspended in a buffer containing 0.6 M mannitol, 431 
20 mM Hepes/KOH pH 7.4, 1 mM EGTA, 0.2% bovine serum albumin (BSA) at approximately 10 mg 432 
of protein/ml. For the proteomic analysis, mitochondria were further purified using a 433 
discontinuous sucrose gradient as described [78]. 434 
Proteomic analysis by shotgun mass spectrometry and label free quantification 435 
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After reduction and derivatisation [79], the mitochondrial proteins were digested with trypsin 436 
sequence grade (Roche) for 16 h at 37 °C using a protein:trypsin ratio of 20:1 [80]. LC-ESI-MS/MS 437 
analysis was performed on a Dionex UltiMate 3000 HPLC System with a PicoFrit ProteoPrep C18 438 
column (200 mm, internal diameter of 75 μm) (New Objective, USA). Gradient: 1% ACN in 0.1 % 439 
formic acid for 10 min, 1-4 % ACN in 0.1% formic acid for 6 min, 4-30% ACN in 0.1% formic acid for 440 
147 min and 30-50 % ACN in 0.1% formic for 3 min at a flow rate of 0.3 μl/min. The eluate was 441 
electrosprayed into an LTQ Orbitrap Velos (Thermo Fisher Scientific, Bremen, Germany) through a 442 
Proxeon nanoelectrospray ion source (Thermo Fisher Scientific) as previously described [81]. Data 443 
acquisition was controlled by Xcalibur 2.0 and Tune 2.4 software (Thermo Fisher Scientific). Mass 444 
spectra were analysed using MaxQuant software (version 1.3.0.5). The spectra were searched by 445 
the Andromeda search engine against the Uniprot sequence database Saccharomyces cerevisiae 446 
CEN.PK113-7D (release 15.12.2016). Protein identification required at least one unique or razor 447 
peptide per protein group (FDR 0.01). Quantification in MaxQuant was performed using the built 448 
in XIC-based label free quantification (LFQ) algorithm using fast LFQ  449 
Statistical analyses were performed using the Perseus software (version 1.5.5.3, 450 
www.biochem.mpg.de/mann/tools/). An Anova test (FDR 0.05) was carried out to identify 451 
proteins differentially expressed among the different conditions. PCA analysis was performed by 452 
Perseus software. Focusing on specific comparison, proteins were considered differentially 453 
expressed if they were present only in one condition or showed significant t-test (p value = 0.05). 454 
Bioinformatic analyses were carried out by YeastMine software 455 
(http://yeastmine.yeastgenome.org) to cluster enriched annotation groups of Biological Processes 456 
and Kegg Pathways within the set of identified proteins. Functional grouping was based on p-value 457 
≤0.05 and at least two counts. The mass spectrometry proteomics data have been deposited to 458 
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the ProteomeXchange Consortium via the PRIDE [82] partner repository with the dataset identifier 459 
PXD007644.  460 
Oxygen Consumption 461 
Oxygen consumption by isolated mitochondria was determined at 30 °C using an Oxygraph-2 k 462 
system (Oroboros, Innsbruck, Austria) equipped with two chambers in a buffer containing 0.6 M 463 
mannitol, 20 mM Hepes/KOH pH 6.8, 10 mM potassium phosphate pH 6.8, 2 mM MgCl2, 1 mM 464 
EGTA, and 0.1% BSA. Data was analysed using DatLab software. Measurements were started by 465 
adding 1.25 mM NADH or 5 mM succinate, followed by the addition of 0.25 mM ADP.  466 
Statistical analysis 467 
Data are reported as means ± SDs from at least three independent experiments. Statistical 468 
significance of the measured differences was assessed by two-tailed Student’s t-test (* p < 0.05). 469 
 470 
 471 
 472 
 473 
474 
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 497 
Table 1. Yeast strains used in this study. 498 
Strain Genotype Origin 
wt CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 [49] 
snf1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
snf1::HPH 
This study 
mpc1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
mpc1::NAT1 
This study 
mpc1Δ snf1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
mpc1::NAT1 snf1::HPH 
This study 
W303 [ACC1-HA reporter] 
W303-1A leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 
his3-11,15 [pYX242-ACC1-GFP-HA] 
This study 
W303 [ACC1-S79A-HA reporter] 
W303-1A leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 
his3-11,15 [pYX242-ACC1-S79A-GFP-HA] 
This study 
Mpc1-4HA 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 MPC1-
4HA:KANMX4 
This study 
Mpc1-4HA snf1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
snf1::HPH MPC1-4HA:KANMX4 
This study 
Mpc2-4HA 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 MPC2-
4HA:KANMX4 
This study 
Mpc2-4HA snf1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
snf1::HPH MPC2-4HA:KANMX4 
This study 
Mpc3-4HA 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 MPC3-
4HA:KANMX4 
This study 
Mpc3-4HA snf1Δ 
CEN.PK JT4 MATa URA3 LEU2 TRP1 HIS3 LCR1 
snf1::HPH MPC3-4HA:KANMX4 
 
 499 
 500 
Figure legends 501 
Figure 1. Methionine addition impairs the growth rate of the snf1Δ mutant.  502 
(A) Snf1 activity was evaluated in wt cells grown with or without 0.1 g/l methionine and expressing 503 
the Acc1-pS79 reporter or the non-phosphorylatable Acc1-S79A version. The asterisk indicates a 504 
non-specific protein band recognized by the anti-HA antibody, used as loading control. (B) Mass 505 
duplication time (MDT) of wt and snf1Δ cells grown in the presence of the indicated 506 
concentrations of methionine. *p<0.05 (C) Glucose and methionine consumption rate, ethanol, 507 
acetate and glycerol secretion rates of wt and snf1Δ cells grown in the presence or absence of 0.1 508 
g/l methionine. *p<0.05. 509 
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Figure 2. Metabolomic analysis of wt and snf1Δ cells grown in the presence or absence of 510 
methionine (0.1 g/l). 511 
(A) wt and snf1Δ cells were collected in exponential phase and cell lysates were analyzed by 512 
GC/MS spectrometry as reported in material and methods. Heat map diagram shows the log2 513 
differential levels of the indicated metabolites. (B) Schematic representation of the methionine 514 
cycle in yeast. Solid arrows indicate direct reactions, while dashed arrows indicate reactions with 515 
multiple steps. (C) Relative levels of S-adenosylmethionine (SAM) and S-adenosylhomocysteine 516 
(SAH) in wt and snf1Δ cells. *p<0.05. (D) Ratio between SAM and SAH in wt and snf1Δ cells. 517 
*p<0.05.  518 
Figure 3. Mitochondrial proteome analysis of wt and snf1Δ cells grown in the presence or 519 
absence of methionine (0.1 g/l). 520 
(A) Venn diagram of the shotgun proteomic analysis on mitochondria purified from wt and snf1Δ 521 
cells grown with or without methionine. (B) Principal component analysis of the proteins common 522 
among the data sets of wt and snf1Δ cells in the presence or absence of 0.1 g/L methionine, whose 523 
differences were statistically significant according to ANOVA test (FDR 0.05). (C-F) Biological 524 
process enrichment analysis of the proteins differentially expressed between the following pairs of 525 
conditions: snf1Δ vs wt (C), wt+M vs wt (D), snf1Δ+M vs snf1Δ (E) and snf1Δ+M vs wt+M (F). For 526 
each comparison, BP-enrichment classes with the lowest p-value are shown. For the full lists see 527 
Supplementary Tables S3-S6. Bars represent the number of annotated genes in the input list. 528 
Figure 4. Methionine addition stimulates mitochondrial respiration in cells lacking Snf1. 529 
(A) Relative mtDNA copy numbers of wt and snf1Δ cells grown in the presence or absence of 0.1 530 
g/l methionine. (B) Ratio between mitochondrial membrane potential and total mitochondrial 531 
content of wt and snf1Δ cells grown in the presence or absence of 0.1 g/l methionine. Data were 532 
obtained by flow cytometric analysis with DiOC6 staining to evaluate the mitochondrial potential 533 
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and with Mitotracker Green staining to measure the total mitochondrial content. *p<0.01. (C) 534 
Respiration rate of isolated mitochondria from wt and snf1Δ cells grown in the presence or 535 
absence of 0.1 g/l methionine, in the presence of the indicated oxidizable substrates. *p<0.02. (D) 536 
Effect of 1 µg/ml antimycin A on mass duplication time (MDT) of wt and snf1Δ cells grown in the 537 
presence or absence of 0.1 g/l methionine. * p<0.001. (E) ATP relative level of wt and snf1Δ cells 538 
grown in the presence or absence of 0.1 g/l methionine. *p<0.005. 539 
Figure 5. Methionine addition enhances mitochondrial pyruvate transport in cells lacking Snf1. 540 
(A) Schematic representation of changes in flux through metabolic pathways in snf1Δ+M relative 541 
to wt+M. (B) Pyruvate transport into mitochondria in wt and snf1Δ cells determined by metabolic 542 
flux analysis as mmoles of pyruvate per 100 mmoles of glucose taken up by yeast cells. (C) 543 
Oxidative TCA cycle activity in wt and snf1Δ cells, reported as percentage of mitochondrial 544 
oxaloacetate produced from the TCA cycle activity and calculated from 13C-labeling patterns of 545 
proteinogenic aminoacids, as described [49].  546 
Figure 6. Cells lacking Snf1 depend on Mpc1 activity. (A) Mpc1,2,3 levels in wt and snf1Δ cells 547 
expressing HA-tagged versions of the three proteins, grown with or without 0.1 g/l methionine. 548 
Anti-Cdc34 antibody was used as loading control. (B) Mass duplication time (MDT) of wt, snf1Δ 549 
treated with 50 µM UK5099, in the presence or absence of 0.1 g/L methionine. *p<0.05. (C) (B) 550 
Mass duplication time (MDT) of wt, snf1Δ, mpc1Δ and mpc1Δsnf1Δ cells grown in the presence or 551 
absence of 0.1 g/L methionine. *p<0.05. (D) Effect of 1 µg/ml antimycin A on mass duplication 552 
time (MDT) of mpc1Δ and mpc1Δsnf1Δ cells grown in the presence or absence of 0.1 g/l 553 
methionine.  554 
Figure 7. Relevant connections between Snf1 and methionine metabolism. Schematization of the 555 
role of Snf1 and methionine cycle on cellular metabolism. Methionine cycle activates 556 
mitochondrial functions and stimulates Snf1/AMPK activity. Snf1/AMPK inhibits glucose uptake 557 
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from the medium, pyruvate flux into the mitochondria and respiration. Snf1-dependent function 558 
in fine tuning methionine metabolism in a feedback loop is also shown [39].  559 
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Supplementary Figure Legends 
Figure S1. (A) Mass duplication time (MDT) of wt and snf1Δ cells in the presence or absence of 0.67 
mM (0.1 g/l) methionine or 0.2 mM S-adenosylmethionine (SAM). * p<0.05. (B) Budding index of wt 
and snf1Δ cells exponentially growing in the presence or absence of 0.1 g/l methionine. 
Figure S2. (A) PCA scores plot of GC/MS analysis showing the distinct clustering for the biological 
replicates of the four conditions, i.e. wt (brown squares), wt+M (brown triangles), snf1Δ (red 
squares), snf1Δ+M (red triangles). (B) Table of the fold changes (expressed as log2) of the heat map 
diagrams shown in Figure 2A.  
Figure S3.  Workflow of the proteomic analysis of Figure 3. 
Figure S4.  Lipid droplet content of wt and snf1Δ cells grown in the presence or absence of 0.1 g/l 
methionine. Data were obtained by Flow Cytometric Analysis with BODIPY staining. *p<0.05.  
Figure S5. (A) Intracellular flux ratios (fraction of cytosolic oxaloacetate originating from cytosolic 
pyruvate, fraction of mitochondrial oxaloacetate derived through anaplerosis, fraction of 
phosphoenol-pyruvate originating from cytosolic oxaloacetate, upper and lower bounds of 
mitochondrial pyruvate derived through malic enzyme) (Blank and Sauer, 2004) calculated using the 
mass isotopomer distribution of proteinogenic amino acids and the software FIAT FLUX (Zamboni et 
al., 2005). (B) Relative distribution of absolute carbon fluxes in wt and snf1Δ grown in 2% glucose in 
the presence or absence of 0.1 g/L methionine. All fluxes, given in the same order in each box, are 
normalized to the specific glucose uptake rate, which is shown in the top inset. Relative fluxes are 
reported in blue for the wt, cyan for the wt+M, red for snf1Δ and pink for snf1Δ+M.  
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Supplementary Table Legends 
Table S1. Raw data of metabolic analysis, related to Fig. 2, S2 
Table S2. List of the proteins common among wt and snf1Δ grown in the presence or absence of 
0.1 g/L methionine whose differences were statistically significant according to ANOVA test (FDR 
0.05). X indicates the proteins described as mitochondrial according to Yeast Mine software and 
(Morgenstern et al., 2017).  
Table S3. List of the proteins differentially expressed in the snf1Δ mutant in comparison with wt. 
X indicates the proteins described as mitochondrial according to Yeast Mine software and 
(Morgenstern et al., 2017) , Z the proteins described as mitochondrial according to (Morgenstern et 
al., 2017).  Biological process enrichments and KEGG pathway enrichments for up-regulated and 
down-regulated proteins are shown. 
Table S4. List of the proteins differentially expressed in wt grown in the presence or absence of 
0.1 g/L methionine. X indicates the proteins described as mitochondrial according to Yeast Mine 
software and (Morgenstern et al., 2017), Z the proteins described as mitochondrial according to 
(Morgenstern et al., 2017). Biological process enrichments and KEGG pathway enrichments for up-
regulated and down-regulated proteins are shown. 
Table S5. List of the proteins differentially expressed in snf1Δ cells grown in the presence or 
absence of 0.1 g/L methionine. X indicates the proteins described as mitochondrial according to 
Yeast Mine software and (Morgenstern et al., 2017), Z the proteins described as mitochondrial 
according to (Morgenstern et al., 2017). Biological process enrichments and KEGG pathway 
enrichments for up-regulated and down-regulated proteins are shown. 
Table S6. List of the proteins differentially expressed in the snf1Δ mutant in comparison with wt 
both grown in the presence of 0.1 g/L methionine. X indicates the proteins described as 
mitochondrial according to Yeast Mine software and (Morgenstern et al., 2017), Z the proteins 
described as mitochondrial according to (Morgenstern et al., 2017). Biological process enrichments 
and KEGG pathway enrichments for up-regulated and down-regulated proteins are shown. 
 
Supplementary Figure S1
0
50
100
150
200
250
M
D
T
 (
m
in
)
*
*
*
*
Budding
Index
wt 87±4%
wt+M 80±4%
snf1Δ 83±2%
snf1Δ+M 68±4%
A B
Supplementary Figures (for online publication)
Click here to download Supplementary Material (for online publication): Supplementary Figures REVISIONE BBA.pdf
Supplementary Figure S2
A
Others wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
1,3-Propanediol 0.05 0.18 0.26 0.21
9H-purine-6-amine 0.45 0.36 0.30 -0.15
Acetanilide 0.06 0.18 0.27 0.21
Acetyl-glutamic acid -1.02 0.64 1.11 2.12
Benzoic acid -0.19 -0.75 0.08 0.26
Citraconic acid 0.49 0.71 0.89 0.40
Cysteinylglycine 0.12 0.20 0.34 0.23
Cytosine -0.06 0.06 0.28 0.34
Dihydrouracil -0.26 0.20 0.33 0.58
Dihydroxyphenylglycine 0.22 1.43 2.12 1.90
Malonic Acid -1.05 0.70 0.40 1.44
Nicotinic acid -0.13 0.76 1.40 1.53
Oxalic acid 0.11 0.28 0.40 0.29
Phenethylamine -2.10 -0.15 -0.67 1.43
Phosphoric acid -0.21 0.03 0.31 0.52
Pyroglutamic acid -1.16 0.80 0.58 1.74
Urea Cycle wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
N-acetyl-Ornithine  2 -0.90 0.30 0.44 1.34
Ornithine -0.81 0.90 1.09 1.90
Citrulline -0.74 0.65 0.70 1.44
Methionine Cycle wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
Methionine 7.32 0.38 9.75 2.42
Homocysteine 6.17 1.11 7.55 1.38
Glycolysis and Trehalose Cycle wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
Dihydroxyacetone phosphate -0.53 -0.70 -1.39 -0.86
Fructose-1,6-diphosphate 0.03 -0.58 -0.62 -0.65
Glucose-6-phosphate -0.72 -0.96 -1.64 -0.92
Pyruvic acid 0.11 0.58 1.14 1.03
Trehalose 0.85 2.32 7.22 6.37
Pentose phosphate pathway wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
6-Phosphogluconic acid -0.49 -0.98 -0.98 -0.49
Ribose-5-phosphate -0.33 -0.81 -1.28 -0.95
Amino acids wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
Alanine 0.14 0.21 0.36 0.22
Aspartic acid -0.40 1.19 2.14 2.54
Glutamic acid -1.34 0.77 1.21 2.55
Glutamine -2.58 1.63 0.68 3.27
Glycine -2.57 -0.18 -1.04 1.53
Homoserine -0.80 0.51 0.48 1.28
Isoleucine -2.25 0.53 -0.50 1.75
Phenylalanine 0.31 0.41 0.58 0.27
Serine -1.08 0.65 0.36 1.44
Succinylhomoserine -0.18 1.06 2.13 2.31
Threonine -1.20 0.70 0.79 2.00
Valine -3.32 0.77 -0.96 2.36
Lysine 0.46 -0.52 0.45 -0.01
Glycerol and lipids wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
allo-Inositol 0.39 0.33 0.16 -0.23
Capric acid 0.14 0.23 0.43 0.29
Glycerol -0.99 0.77 0.71 1.70
Glycerol 1-phosphate -0.20 1.05 1.75 1.95
Linoleic acid 0.15 0.25 0.47 0.32
methyl Oleate 0.80 0.58 0.42 -0.38
myo-Inositol -0.41 0.26 0.72 1.13
Palmitic acid 0.08 0.23 0.59 0.51
Stearic acid 0.20 0.26 0.69 0.49
Stearoyl-Glycerol 1.06 0.70 1.48 0.42
TCA Cycle wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
Citric acid 0.18 0.80 2.10 1.92
Fumaric acid -1.11 -0.23 0.42 1.53
Malic acid -0.68 -0.10 0.89 1.57
Glyoxylate Cycle wt +  M / wt snf1Δ / WT snf1Δ + M / wt snf1Δ +  M / wt + M
Glyoxylic acid 0.02 0.14 0.34 0.32
B
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cytOAA from cytPYR
mtOAA from 
anaplerosis
malic enzyme lower 
bound
malic enzyme upper 
bound
PEP from cytOAA
mean mean mean mean mean
wt 0.906 ± 0.028 0.954 ± 0.017 0.027 ± 0.016 0.387 ± 0.236 0.045 ± 0.013
wt + M 0.932 ± 0.027 0.785 ± 0.016 0.061 ± 0.015 0.419 ± 0.076 0.050 ± 0.040
snf1Δ 0.919 ± 0.029 0.708 ± 0.018 0.022 ± 0.016 0.070 ± 0.052 0.076 ± 0.014
snf1Δ + M 0.886 ± 0.026 0.530 ± 0.016 0.064 ± 0.016 0.235 ± 0.267 0.032 ± 0.016
A
B
wt 100% = 23.23 mmol/(g*h)
wt+M 100% = 20.85 mmol/(g*h)
snf1Δ 100% = 14.11 mmol/(g*h)
snf1Δ+M 100% = 12.69 mmol/(g*h)
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[5950] L-alanine 1 [7.4748]9.548866 8.930075 8.898563 8.805892 8.818842 9.059486 8.9934 9.37414
[867] malonic acid 1 [8.919]7.4786 5 6.853664 6.96526 6.991457 6.476352 6.053428 5.189891 6.99103
[5962] L-lysine 2 [17.643]13.05655 12.60086 12.70614 12.84879 12.6808 13.38929 12.53192 14.06714
[70914] N-acetyl-L-glutamic acid 1 [13.063]16.02912 14.69884 14.62217 14.876 15.08025 14.01597 13.141 15.04866
[311] citric acid [16.615]12.72457 11.67382 11.76415 11.90613 12.02221 12.30239 11.2854 12.95198
[791] DL-isoleucine 2 [10.225]11.01494 9.830399 9.990864 9.955319 10.02017 7.837225 7.201081 8.766426
[328] DL-4-hydroxymandelic acid [16.126]5.747741 4.738308 5.238764 5.504828 5.061005 5.544423 5.529748 5.683978
[597] cytosine 2 [13.255]10.20228 8.852299 8.807695 8.807996 8.833857 8.864298 8.895675 9.26166
[985] palmitic acid [18.846]14.07733 13.40899 12.08698 13.42477 13.40085 12.0543 13.5764 13.83565
[750] glycine [10.456]12.91456 11.73319 11.74455 11.95168 12.0074 9.532492 8.960822 10.36131
[6288] L-threonine 2 [11.464]11.53283 1.53806 11.7869 11.75227 11.79215 10.64357 9.625159 11.60604
[91493] 6-phosphogluconic acid [22.289]9.922213 8.856834 9 146925 9.356637 9.494328 8.548975 8.302884 9.947588
[65270] cysteinylglycine 3 [18.946]9.437399 8.9058 5 8.912449 8.80709 8.896872 8.998928 8.944282 9.296968
[5960] aspartic acid 2 [13.207]13.85409 13.16653 13.26074 13.24407 13.06951 13.45056 12.38728 14.10605
[439579] L-homocystine 3 [23.039]5.947633 5.0307 4 4.903676 5.218043 4.807577 11.28717 10.07708 12.8468
[12647] L-homoserine 2 [12.359]8.591826 7.590035 7.923353 7.982308 7.700054 7.197647 6.552747 8.015196
[6262] L-ornithine 2 [16.632]11.52903 11. 0758 11.08132 11.76983 11.4785 10.66391 9.804477 11.53026
[892] myo-inositol [19.354]8.430027 7.214488 7.71946 7.586292 7.398889 7.525226 6.715354 7.890443
[904] acetanilide 2 [11.346]14.57129 13.91649 13.87782 13.8192 13.9529 13.98131 13.99648 14.26211
[5281] stearic acid [20.675]15.89922 15.22218 13.74679 15.32808 15.2602 14.03113 15.52341 15.79301
[33032] L-glutamic acid 1 [13.338]13.94971 12.69174 12.78355 12.83867 13.09004 11.99398 10.61809 13.3365
[7427] D-(+) trehalose [24.752]7.757687 6.9 2048 7.230052 7.183782 7.341092 8.161732 7.580984 8.868601
[24699] 1-stearoyl-rac-glycerol [24.913]10.01086 9.184942 8.497473 11.45408 9.456961 8.627205 11.73563 11.99827
[6137] L-methionine 2 [13.188]11.93181 0 6 636 10.80899 10.90564 10.94911 12.95597 11.97455 13.65359
[5951] L-serine 2 [11.174]13.47065 12.74963 12.85502 12.90185 12.48064 12.03461 10.55458 12.93794
[5280450] linoleic acid [20.399]12.99612 12.41145 12.37187 12.44687 12.49737 12.52268 12.56889 12.8732
[243] benzoic acid [9.594]13.2907 12.20857 12.48434 12.6332 12.7822 12.4202 12.13962 12.8354
[439167] D-ribose-5-phosphate 2 [19.548]9.778563 8.86767 9.162344 9.358911 9.429152 8.548975 8.346555 9.872774
[2969] capric acid [12.399]10.5232 .781584 9.807175 10.01041 10.02015 9.908701 10.13129 10.50875
[971] oxalic acid [7.883]6.70523 6.161531 5.943542 6.101486 6.260603 6.066575 6.247668 6.523795
[994] Phenylalanine 1 [13.545]5.453515 4.65935 5.352079 5.083129 4.748458 5.638798 5.350328 5.494621
[938] nicotinic acid [10.27]9.460487 8.343735 8.599093 8.673839 8.581425 8.594143 7.967837 9.295187
[738] L-glutamine 1 [13.431]12.05924 10.88788 11.4881 11.37614 10.58505 9.008822 7.814986 9.593386
[5960] aspartic acid 1 [12.002]12.78528 10.74884 10.89669 11.12463 11.49143 11.24862 9.962876 12.35226
[1060] pyruvic acid [6.714]8.901827 8.005096 8.157452 8.134126 8.506537 8.428444 7.846849 9.143993
[10267] fructose-1,6-diphosphate 2 [24.57]6.090731 6.252999 4.968256 6.658807 7.742334 5.347035 5.206958 7.378145
[92824] D-malic acid [12.794]8.907558 7 538001 7.679023 7.709544 7.819492 7.37578 6.481913 8.103207
[439232] N-acetyl-ornithine  2 [18.409]11.1338 9.486794 9.365047 9.754441 10.37804 9.029093 8.224179 10.14431
[638129] citraconic acid [10.792]8.362603 8. 24504 7.700724 8.284537 8.407906 8.210753 8.623206 8.986523
[10442] 1,3-propanediol [6.777]10.77517 10 1392 10.1116 10.07462 10.15803 10.20518 10.20393 10.47639
[439958] D-glucose-6-phosphate 2 [21.558]11.6485 10.78916 10.96 11 11.54069 11.93806 10.50642 9.845544 11.8057
[754] glycerol 1-phosphate [16.056]9. 05211 7.83145 7.780546 7.914153 8.223545 7.920092 7.720878 8.531666
[892] allo-inositol  [17.245]7.493501 6.771367 9.00119 7.662946 6.859564 9.050776 7.769261 8.03162
[443586] 3,5-dihydroxyphenylglycine  2 [18.124]6.687738 6.221756 5.7753 6.445354 6.761925 6.181258 6.037915 7.368023
[760] glyoxylic acid [10.813]10.23754 9.647776 9.363968 9.56005 9.701389 9.407194 9.605592 9.910625
[649] 5,6-dihydrouracil 1 [12.314]15.04297 14.0637 14.21313 14.17358 14.2047 14.18281 13.80712 14.4406
[33032] L-glutamic acid 2 [14.398]13.64562 13.08451 12.8704 13.17358 13.21179 11.97056 10.53225 13.11682
[668] dihydroxyacetone phosphate 1 [15.804]8.208009 7.105441 7.323817 7.547369 7.760975 6.952872 6.342217 7.791546
[1004] phosphoric acid [9.966]14.35853 13.42785 13.59234 13.64763 13.92335 13.50151 13.21352 13.93939
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Protein 
ID Gene Protein names Length
P38631 FKS1_YEAST 1,3-beta-glucan synthase component FKS1 (EC 2.4.1.34) (1,3-beta-D-glucan-UDP glucosyltransferase) (Calcineurin dependent protein 1) (Calcofluor white hypersensitivity protein 53) (Echinocandin target gene protein 1) (FK506 sensitivity protein 1) (Glucan synthase of cerevisiae protein 1) (Papulacandin B resistance protein 1)1876
P32621 GDA1_YEAST Guanosine-diphosphatase (GDPase) (EC 3.6.1.42) 518
P53171 GEP7_YEAST Genetic interactor of prohibitin 7, mitochondrial 287
P41921 GSHR_YEAST Glutathione reductase (GR) (GRase) (EC 1.8.1.7) 483
P21954 IDHP_YEAST Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)428
P32466 HXT3_YEAST Low-affinity glucose transporter HXT3 567
P28241 IDH2_YEAST Isocitrate dehydrogenase [NAD] subunit 2, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase) (NAD(+)-specific ICDH)369
P30605 ITR1_YEAST Myo-inositol transporter 1 584
P06208 LEU1_YEAST 2-isopropylmalate synthase (EC 2.3.3.13) (Alpha-IPM synthase) (Alpha-isopropylmalate synthase)619
P42838 LEM3_YEAST Alkylphosphocholine resistance protein LEM3 (Brefeldin-A sensitivity protein 3) (Ro-sensitive 3)414
P40513 MAM33_YEAST Mitochondrial acidic protein MAM33 266
P17505 MDHM_YEAST Malate dehydrogenase, mitochondrial (EC 1.1.1.37) 334
Q12285 MDY2_YEAST Ubiquitin-like protein MDY2 (Golgi to ER traffic protein 5) (Mating-deficient protein 2) (Translation machinery-associated protein 24)212
P40185 MMF1_YEAST Protein MMF1, mitochondrial (Isoleucine biosynthesis and maintenance of intact mitochondria 1) (Maintenance of mitochondrial function 1)145
P33201 MRT4_YEAST Ribosome assembly factor MRT4 (mRNA turnover protein 4)236
P10507 MPPB_YEAST Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) (PEP)462
Q07938 MTAP_YEAST S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase) (Multicopy enhancer of UAS2)337
P49954 NIT3_YEAST Probable hydrolase NIT3 (EC 3.5.-.-) 291
P32340 NDI1_YEAST Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial (EC 1.6.5.9) (Internal NADH dehydrogenase) (NADH:ubiquinone reductase (non-electrogenic))513
P32860 NFU1_YEAST NifU-like protein, mitochondrial 256
Q12428 PRPD_YEAST Probable 2-methylcitrate dehydratase (2-MC dehydratase) (EC 4.2.1.79) ((2S,3S)-2-methylcitrate dehydratase)516
P07257 QCR2_YEAST Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)368
P37299 QCR10_YEAST Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 8.5 kDa protein)77
P00128 QCR7_YEAST Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase c reductase complex 14 kDa protein)127
P07256 QCR1_YEAST Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)457
P0CX41 RL23A_YEAST 60S ribosomal protein L23-A (L17a) (Large ribosomal subunit protein uL14-A) (YL32)137
P36528 RM17_YEAST 54S ribosomal protein L17, mitochondrial (Mitochondrial large ribosomal subunit protein mL46) (YmL17/YmL30)281
P20435 RPAB2_YEAST DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (ABC23) (DNA-directed RNA polymerases I, II, and III 23 kDa polypeptide)155
Q12487 RM23_YEAST 54S ribosomal protein L23, mitochondrial (Mitochondrial large ribosomal subunit protein uL13m) (YmL23)163
Q00711 SDHA_YEAST Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (FP)640
P21825 SEC62_YEAST Translocation protein SEC62 (Sec62/63 complex 30 kDa subunit)274
Q99287 SEY1_YEAST Protein SEY1 (EC 3.6.5.-) (Synthetic enhancer of YOP1 protein)776
P00445 SODC_YEAST Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) 154
P00447 SODM_YEAST Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) 233
P0CF17 U5072_YEAST UPF0507 protein YML002W 737
P08067 UCRI_YEAST Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 1.10.2.2) (Complex III subunit 5) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c reductase iron-sulfur subunit)215
P32316 ACH1_YEAST Acetyl-CoA hydrolase (EC 3.1.2.1) (Acetyl-CoA deacylase) (Acetyl-CoA acylase)526
P32317 AFG1_YEAST Protein AFG1 509
P23180 AIM17_YEAST Probable oxidoreductase AIM17 (EC 1.14.11.-) (Altered inheritance of mitochondria protein 17, mitochondrial) (Found in mitochondrial proteome protein 12)465
Q01976 ADPP_YEAST ADP-ribose pyrophosphatase (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase)231
Q04728 ARGJ_YEAST Arginine biosynthesis bifunctional protein ArgJ, mitochondrial (Extracellular mutant protein 40) [Cleaved into: Arginine biosynthesis bifunctional protein ArgJ alpha chain; Arginine biosynthesis bifunctional protein ArgJ beta chain] [Includes: Glutamate N-acetyltransferase (GAT) (EC 2.3.1.35) (Ornithine acetyltransferase) (OATase) (Ornithine transacetylase); Amino-acid acetyltransferase (EC 2.3.1.1) (N-acetylglutamate synthase) (AGS)]441
P07251 ATPA_YEAST ATP synthase subunit alpha, mitochondrial 545
Q12165 ATPD_YEAST ATP synthase subunit delta, mitochondrial (F-ATPase delta subunit)160
P05626 ATPF_YEAST ATP synthase subunit 4, mitochondrial 244
P00830 ATPB_YEAST ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) 511
P32451 BIOB_YEAST Biotin synthase, mitochondrial (EC 2.8.1.6) 375
P14066 CBS1_YEAST Cytochrome b translational activator protein CBS1, mitochondrial (COB-specific translational activator protein CBS1)229
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Protein ID Gene
N1NWR5 SIL1
N1P175 AIM25
N1P9Y0 PDX1
N1P4D6 ZIM17
N1P520 QCR6
N1P1I4 SEC72
N1P2V2 ZRT1
N1P9X9 CRH1
N1P227 AIM23
N1P1U0 CCW14
N1P7X1 ATP16
N1PAC3 PST1
N1NVJ9 RPL43A
N1NZ71 YBT1
N1P1X3 GEP7
N1P797 ECM11
N1P7M3 ADE1
N1P998 TMA108
N1NYB6 APS1
P32366 VMA6
N1P2G2 SDP1
Q99380 OST4
P34166 MFA2
P54114 ALD3
Q3E752 YPR036W-A
P40089 LSM5
Q3E795 YLR361C-A
Q12306 SMT3
Q06139 YLR346C
P22943 HSP12
P38841 YHR138C
P10663 MRP2
P27999 RPB9
P26755 RFA3
P38155 PAU24
P40045 TDA2
P38783 FYV4
Q12127 CCW12
Dow-regulated in snf1 Δ
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Protein ID Gene Protein names
P53171 GEP7 Genetic interactor of prohibitin 7, mitochondrial
P14742 GFA1 Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (GFAT)  (D-fructose-6-phosphate amidotransferase) (Hexosephosphate aminotransferase)
P48015 GCV1 Aminomethyltransferase, mitochondrial  (Glycine cleavage system T protein) (GCVT) (Glycine decarboxylase complex subunit T)
P38988 GGC1 Mitochondrial GTP/GDP carrier protein 1
P21954 IDP1 Isocitrate dehydrogenase [NADP], mitochondrial (IDH)  (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)
P19882 HSP60 Heat shock protein 60, mitochondrial (CPN60) (P66) (Stimulator factor I 66 kDa component)
P28241 IDH2 Isocitrate dehydrogenase [NAD] subunit 2, mitochondrial  (Isocitric dehydrogenase) (NAD(+)-specific ICDH)
P28834 IDH1 Isocitrate dehydrogenase [NAD] subunit 1, mitochondrial (Isocitric dehydrogenase) (NAD(+)-specific ICDH)
P39522 ILV3 Dihydroxy-acid dehydratase, mitochondrial (DAD)  (2,3-dihydroxy acid hydrolyase)
P06208 LEU4 2-isopropylmalate synthase (Alpha-IPM synthase) (Alpha-isopropylmalate synthase)
P40513 MAM33 Mitochondrial acidic protein MAM33
P17505 MDH1 Malate dehydrogenase, mitochondrial 
P40185 MMF1 Protein MMF1, mitochondrial (Isoleucine biosynthesis and maintenance of intact mitochondria 1) (Maintenance of mitochondrial function 1)
P38162 MIX23 Mitochondrial intermembrane space cysteine motif-containing protein MIX23 (Mitochondrial intermembrane space CX(n)C motif protein of 23 kDa)
Q08818 MSC6 Meiotic sister-chromatid recombination protein 6, mitochondrial
P23641 MIR1 Mitochondrial phosphate carrier protein (Mitochondrial import receptor) (Phosphate transport protein) (PTP) (mPic 1) (p32) [Cleaved into: Mitochondrial phosphate carrier protein, N-terminally processed]
Q12117 MRH1 Protein MRH1 (Membrane protein related to HSP30)
P11914 MAS2 Mitochondrial-processing peptidase subunit alpha  (Alpha-MPP)
P10507 MAS1 Mitochondrial-processing peptidase subunit beta  (Beta-MPP) (PEP)
P25270 MRM1 rRNA methyltransferase 1, mitochondrial  (21S rRNA (guanosine(2270)-2'-O)-methyltransferase) (21S rRNA [Gm2270] 2'-O-methyltransferase) (Mitochondrial large ribosomal RNA ribose methylase) (Petite colonies protein 56)
P53166 MRH4 ATP-dependent RNA helicase MRH4, mitochondrial  (Mitochondrial RNA helicase 4)
P32340 NDI1 Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial  (Internal NADH dehydrogenase) (NADH:ubiquinone reductase (non-electrogenic))
P32860 NFU1 NifU-like protein, mitochondrial
P38848 PEX28 Peroxisomal membrane protein PEX28 (Peroxin-28)
Q12428 PDH1 Probable 2-methylcitrate dehydratase (2-MC dehydratase)  ((2S,3S)-2-methylcitrate dehydratase)
P07257 QCR2 Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)
P37299 QCR10 Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 8.5 kDa protein)
P00128 QCR7 Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (Ubiquinol-cytochrome c reductase c reductase complex 14 kDa protein)
P07256 COR1 Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)
P36528 MRPL17 54S ribosomal protein L17, mitochondrial (Mitochondrial large ribosomal subunit protein mL46) (YmL17/YmL30)
P32388 MRP49 54S ribosomal protein MRP49, mitochondrial (Mitochondrial large ribosomal subunit protein mL61)
Q06678 MRPL35 54S ribosomal protein L35, mitochondrial (Mitochondrial large ribosomal subunit protein mL38) (YmL35)
Q00711 SDH1 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (Flavoprotein subunit of complex II) (FP)
P38827 SET1 Histone-lysine N-methyltransferase, H3 lysine-4 specific  (COMPASS component SET1) (Lysine N-methyltransferase 2) (SET domain-containing protein 1)
Q02208 TOF2 Topoisomerase 1-associated factor 2
P08067 RIP1 Cytochrome b-c1 complex subunit Rieske, mitochondrial  (Complex III subunit 5) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c reductase iron-sulfur subunit)
P07246 ADH3 Alcohol dehydrogenase 3, mitochondrial  (Alcohol dehydrogenase III) (YADH-3)
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Protein ID Gene
P36141 FMP46
P33893 PET112
P00360 TDH1
P53171 GEP7
P39726 GCV3
P41921 GLR1
P38715 GRE3
P32191 GUT2
P21954 IDP1
P28241 IDH2
P33416 HSP78
Q6Q560 ISD11
P36775 PIM1
P06208 LEU4
P40513 MAM33
P17505 MDH1
Q12230 LSP1
P36112 MIC60
P32787 MGM101
Q99257 MEX67
P25573 MGR1
P38341 MIC12
P50945 MIC27
Q03104 MSC1
P40185 MMF1
P40364 MPM1
Q08818 MSC6
P10507 MAS1
Q07938 MEU1
P40215 NDE1
P32340 NDI1
P32860 NFU1
P38921 PET8
P40530 PKP1
P35999 OCT1
P41903 TES1
Q12428 PDH1
P07257 QCR2
P37299 QCR10
P00128 QCR7
P07256 COR1
Up-regulated in snf1Δ+M
Table S5
Click here to download Supplementary Material (for online publication): Table S5_snf1+M-snf1.xlsx
Protein 
ID Gene Protein names
P38631 FKS1 1,3-beta-glucan synthase component FKS1 (1,3-beta-D-glucan-UDP glucosyltransferase) (Calcineurin dependent protein 1) (Calcofluor white hypersensitivity protein 53) (Echinocandin target gene protein 1) (FK506 sensitivity protein 1) (Glucan synthase of cerevisiae protein 1) (Papulacandin B resistance protein 1)
P32621 GDA1 Guanosine-diphosphatase (GDPase) 
P16474 KAR2 78 kDa glucose-regulated protein homolog (GRP-78) (Immunoglobulin heavy chain-binding protein homolog) (BiP)
P47042 IKS1 Probable serine/threonine-protein kinase IKS1  (IRA1 kinase suppressor 1)
P27810 KTR1 Alpha-1,2 mannosyltransferase KTR1 
P42838 LEM3 Alkylphosphocholine resistance protein LEM3 (Brefeldin-A sensitivity protein 3) (Ro-sensitive 3)
Q12404 MPD1 Protein disulfide-isomerase MPD1 
P33201 MRT4 Ribosome assembly factor MRT4 (mRNA turnover protein 4)
P42934 PMT6 Dolichyl-phosphate-mannose--protein mannosyltransferase 6 
P33333 SLC1 Probable 1-acyl-sn-glycerol-3-phosphate acyltransferase (1-AGP acyltransferase) (1-AGPAT) (Lysophosphatidic acid acyltransferase) (LPAAT)
P31382 PMT2 Dolichyl-phosphate-mannose--protein mannosyltransferase 2 
P53131 PRP43 Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP43 (Helicase JA1)
P25560 RER1 Protein RER1 (Retention of ER proteins 1)
P10964 RPA190 DNA-directed RNA polymerase I subunit RPA190 (EC 2.7.7.6) (DNA-directed RNA polymerase I 190 kDa polypeptide) (A190) (DNA-directed RNA polymerase I largest subunit)
P21825 SEC62 Translocation protein SEC62 (Sec62/63 complex 30 kDa subunit)
Q08199 SIL1 Nucleotide exchange factor SIL1 (Protein SLS1)
Q99287 SEY1 Protein SEY1 ( (Synthetic enhancer of YOP1 protein)
P53165 SGF73 SAGA-associated factor 73 (73 kDa SAGA-associated factor) (SAGA histone acetyltransferase complex 73 kDa subunit)
P35209 SPT21 Protein with a role in transcriptional silencing; required for normal transcription at several loci including HTA2-HTB2 and HHF2-HHT2, but not required at the other histone loci
Q12133 SPC3 Signal peptidase complex subunit SPC3 (Microsomal signal peptidase subunit 3)
Q12513 TMA17 Translation machinery-associated protein 17 (ATPase-dedicated chaperone of 17 kDa) (ADC17)
P36017 VPS21 Vacuolar protein sorting-associated protein 21 (GTP-binding protein YPT51) (Vacuolar protein-targeting protein 12)
P21576 VPS1 Vacuolar protein sorting-associated protein 1
P21147 OLE1 Acyl-CoA desaturase 1  (Delta 9 fatty acid desaturase) (Fatty acid desaturase 1) (Stearoyl-CoA desaturase 1)
P53730 ALG12 Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase  (Asparagine-linked glycosylation protein 12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Extracellular mutant protein 39) (Mannosyltransferase ALG12)
P15703 BGL2 Glucan 1,3-beta-glucosidase (Exo-1,3-beta-glucanase) (GP29) (Soluble cell wall protein 9)
P41810 SEC26 Coatomer subunit beta (Beta-coat protein) (Beta-COP)
O13547 CCW14 Covalently-linked cell wall protein 14 (Inner cell wall protein)
P24871 CLB4 G2/mitotic-specific cyclin-4
P32891 DLD1 D-lactate dehydrogenase [cytochrome] 1, mitochondrial (D-lactate ferricytochrome C oxidoreductase) (D-LCR)
P25340 ERG4 Delta(24(24(1)))-sterol reductase  (C-24(28) sterol reductase) (Sterol Delta(24(28))-reductase)
P32462 ERG24 Delta(14)-sterol reductase  (C-14 sterol reductase) (Sterol C14-reductase)
P53337 ERV29 ER-derived vesicles protein ERV29
P43555 EMP47 Protein EMP47 (47 kDa endomembrane protein) (Endosomal P44 protein)
P32476 ERG1 Squalene monooxygenase  (Squalene epoxidase) (SE)
Q12452 ERG27 3-keto-steroid reductase 
Q05040 FAR8 Factor arrest protein 8
P43613 ERJ5 ER-localized J domain-containing protein 5
P32339 HMX1 Heme-binding protein HMX1
P27476 NSR1 Nuclear localization sequence-binding protein (p67)
P38837 NSG1 Protein involved in regulation of sterol biosynthesis
P46964 OST2 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit OST2 (Oligosaccharyl transferase subunit OST2)  (Oligosaccharyl transferase 16 kDa subunit) (Oligosaccharyl transferase subunit epsilon)
Q99380 OST4 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit OST4 (Oligosaccharyl transferase subunit OST4)  (Oligosaccharyl transferase 4 kDa subunit) (OTase 4 kDa subunit)
P53224 ORM1 Protein that mediates sphingolipid homeostasis
P25343 RVS161 Reduced viability upon starvation protein 161
Q03529 SCS7 Ceramide very long chain fatty acid hydroxylase SCS7 (Ceramide VLCFA hydroxylase SCS7) (Suppressor of calcium sensitivity 7)
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